US: 800.298.5699
Int'l: +1.240.747.3093
Latest Research by Email
Receive email alerts of new market research reports in your industry.
Sign Up Today >
|
|
Home > Back to Category >
Report Information
|
Email a colleague
|
Printer format
|
U.S. Congestive Heart Failure Medication Markets
Frost & Sullivan
June 1, 2001 - Pub ID: MC521948
|
|
Questions about this report >
Order by fax >
XE.com
|
|
1. Executive Summary
- A. Market Overview
- 1. Introduction
- 2. Competitive Analysis
- 3. Technologies
- B. Major Research Findings
- 1. Opportunities and Forecasts
- 2. Market Segment Analysis
2. Total Market
- A. Overview and Definitions
- 1. Introduction
- 2. Challenges
- 3. Market Engineering Analysis
- 4. Market Drivers
- 5. Market Restraints
- B. Forecasts and Trends
- 1. Revenue Forecasts
- 2. Demand Analysis
- 3. Market and Technology Trends
- C. Competitive Analysis
- 1. Competitive Structure
- 2. Market Share Analysis
- 3. Product Analysis
- D. Recommendations and Awards
- 1. Strategic Recommendations
- 2. Market Engineering Leadership Award
- 3. Market Engineering Leadership Award, Ace Inhibitor
- 4. Entrepreneurial Company Award: Scios Incorporated
- 5. Product Innovation: Bristol-Myers Squibb Corporation
- 6. Marketing Strategy Awards: King Pharmaceuticals
3. ACE Inhibitor Market
- A. Overview and Definitions
- 1. Introduction
- 2. Challenges
- 3. Market Engineering Analysis
- 4. Market Drivers
- 5. Market Restraints
- B. Forecasts and Trends
- 1. Revenue Forecasts
- 2. Demand Analysis
- 3. Market and Technology Trends
- 4. Pricing Trends
- C. Competitive Analysis
- 1. Competitive Structure
- 2. Market Share Analysis
- 3. Product Analysis
- 4. Off Label Medications
- D. Strategic Recommendations
- 1. Establish Relationships Strategy
- 2. Awareness and Education Strategy
- 3. Reform of Healthcare Payment System Strategy
- 4. Cost Saving Strategy
4. Beta Blockers Market
- A. Overview and Definitions
- 1. Introduction
- 2. Challenges
- 3. Market Engineering Analysis
- 4. Market Drivers
- 5. Market Restraints
- B. Forecasts and Trends
- 1. Revenue Forecasts
- 2. Demand Analysis
- 3. Market and Technology Trends
- 4. Pricing Trends
- C. Competitive Analysis
- 1. Competitive Structure
- 2. Market Share Analysis
- 3. Product Analysis
- 4. Off Label Medications
- D. Recommendations and Evaluation
- 1. Strategic Recommendations
5. Emerging Therapeutics
- A. Overview and Definitions
- 1. Introduction
- 2 Challenges
- 3. Opportunities
- B. Trends
- 1. Market Entrance Forecast
- 2. Demand Analysis
- 3. Market and Technology Trends
- C. Competitive Analysis
- 1. Competitive Structure
- 2. Product Analysis
6. Research Methodology
- A. Terms and Definitions
- 1. Glossary of Terms
- a. Market Definitions
- b. Market Overview
List of Figures
- Chapter 1
- Total Congestive Heart Failure Medications Market: Competitive Structure (U.S.), 2000
- Total Congestive Heart Failure Medications Market: Revenue Forecasts (U.S.), 1997-2007
- Total Congestive Heart Failure Market:Percent of Revenues by Product Type (U.S.),1997-2007
- Chapter 2
- Total Congestive Heart Failure Medications Market: Impact of Top Industry Challenges (U.S.) 2001-2007
- Total Congestive Heart Failure Medications Market: Market Drivers Ranked in Order of Impact (U.S.), 2001-2007
- Total Congestive Heart Failure Medications Market: Market Restraints Ranked in Order of Impact (U.S.), 2001-2007
- Total Congestive Heart Failure Medications Market: Revenue Forecasts (U.S.), 1997-2007
- Total Congestive Heart Failure Market: Percent of Revenues by Product Type (U.S.), 1997-2007
List of Charts
- Chapter 2
- Total Congestive Heart Failure Medications Market: Market Engineering Measurements (U.S.), 2000
- Chapter 3
- Ace Inhibitor Medications Market: Market Engineering Measurements (U.S.), 2000
- Chapter 4
- Beta Blocker Branded Therapeutics Market: Market Engineering Measurements (U.S.), 2000
|
|
|